PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Symptom | C0023895|liver disease |
| Sentences | 81 |
| PubMedID- 26523271 | Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 24809655 | Questions remain about the relationship between type 2 diabetes mellitus (type 2 dm) and the risk of hepatocellular carcinoma (hcc), especially in patients with chronic liver diseases. |
| PubMedID- 26234231 | hepatocellular carcinoma in a patient with polycystic liver disease. |
| PubMedID- 26099526 | Background & aims: alcoholic steatohepatitis (ash) is the progressive form of alcoholic liver disease and may lead to cirrhosis and hepatocellular carcinoma. |
| PubMedID- 26225191 | Liver resection (lr) for hepatocellular carcinoma (hcc) in patients with chronic liver disease (cld) is associated with high risks of developing significant postoperative complications and multicentric metachronous lesions, which can result in the need for repeated treatments. |
| PubMedID- 26202505 | Value of shear wave velocity measurements for the risk assessment of hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease : hcc risk assessment by vttq. |
| PubMedID- 25276280 | Infection by the hcv can cause acute and chronic liver diseases and may lead to cirrhosis, hepatocellular carcinoma or liver failure. |
| PubMedID- 22801423 | Hepatitis c virus (hcv) is the main agent of acute and chronic liver diseases leading to cirrhosis and hepatocellular carcinoma. |
| PubMedID- 26052388 | Aim: to evaluate the association between alpha-1 antitrypsin deficiency (a1atd) and hepatocellular carcinoma (hcc) in patients with end-stage liver disease (esld). |
| PubMedID- 20818940 | Hepatitis c virus (hcv) infection spreads primarily via contact with infected blood and can establish a persistent infection in 80% of infected individuals, progressively causing chronic liver disease that can lead to hepatocellular carcinoma or end-stage liver disease requiring a transplant. |
| PubMedID- 23905912 | Objectives: the incidence of hepatocellular carcinoma associated with nonalcoholic fatty liver disease is increasing. |
| PubMedID- 23828743 | 6 as shown in different studies, nash is associated with increased liver-related mortality due to end-stage liver disease and/or development of hepatocellular carcinoma. |
| PubMedID- 20592927 | For the detection of hepatocellular carcinoma (hcc) in patients with chronic liver disease, gadobenate dimeglumine-enhanced mri has demonstrated a higher sensitivity than has multidetector ct (mdct) for hccs (≤ 1 cm) (11) and gadobenate dimeglumine-enhanced mri has demonstrated a better diagnostic performance than ferucarbotran-enhanced mri (12). |
| PubMedID- 23113141 | To date more than 370 million people are chronically infected with hbv worldwide, leading to chronic liver disease and development of hepatocellular carcinoma (hcc) in many cases. |
| PubMedID- 25785178 | Comparison of the accuracy of dwi and ultrasonography in screening hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 24927176 | Hepatitis c virus (hcv) infection causes chronic liver diseases leading to hepatocellular carcinoma (hcc) and liver failure. |
| PubMedID- 25387451 | This study examined whether glycated hemoglobin a1c (hba1c) and chronic liver diseases are associated with hepatocellular carcinoma (hcc) risk in type 2 diabetic patients. |
| PubMedID- 21743215 | Hcv is a major cause of chronic liver disease that may lead to cirrhosis and hepatocellular carcinoma. |
| PubMedID- 26239358 | Further, 23 % of these patients, if untreated, will eventually develop hepatocellular carcinoma, the primary cause of liver disease induced mortality 7. |
| PubMedID- 25715363 | Objectives: to determine the usefulness of contrast-enhanced sonography using the perfluorobutane contrast agent sonazoid (daiichi-sankyo, tokyo, japan) for establishing the diagnosis and cellular differentiation of hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 22576780 | Background: non-alcoholic fatty liver disease (nafld) can lead to cirrhosis and hepatocellular carcinoma and is strongly associated with obesity and insulin resistance. |
| PubMedID- 25065095 | Objective: to assess the benefit on diagnosis of hepatocellular carcinoma (hcc) in patients with chronic liver disease or cirrhosis with double contrast mr imaging compared to the routine gadolinium-based mr imaging. |
| PubMedID- 23449255 | Chronic alcohol consumption is a leading cause of chronic liver disease worldwide, leading to cirrhosis and hepatocellular carcinoma. |
| PubMedID- 21874252 | Highly sensitive lens culinaris agglutinin-reactive alpha-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 24632765 | Statin therapy seems to be related to a reduced risk for hepatocellular carcinoma in patients with chronic liver disease, but randomized data are lacking. |
| PubMedID- 23884757 | Is liver-specific gadoxetic acid-enhanced magnetic resonance imaging a reliable tool for detection of hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 19760361 | Background: excellent survival obtained with liver transplantation (lt) for limited hepatocellular carcinoma (hcc) in patients with chronic liver disease is still challenged by the increasing discrepancy between candidates and grafts available. |
| PubMedID- 20589433 | Background: as is known for many types of human cancers, the hepatocellular carcinoma (hcc) associated with chronic liver disease shows an obvious multistage process of tumor progression. |
| PubMedID- 23901347 | Several lines of evidence suggest that obi is associated with progression of liver fibrosis and the development of hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 23190006 | Background and aim: the purpose of this study was to perform a meta-analysis of all available studies of the diagnostic performance of diffusion-weighted imaging (dwi) in the detection of hepatocellular carcinoma (hcc) in patients with chronic liver disease. |
| PubMedID- 25560838 | Persistent hcv infection can lead to progressive liver disease with the development of liver cirrhosis and hepatocellular carcinoma, possibly accounting for up to 0.5 million deaths every year. |
| PubMedID- 21234351 | Vitamin a supplementation may be considered since vitamin a deficiency results in nyctalopia and dry cornea, and is associated with increased risk of hepatocellular carcinoma in patients with end-stage liver disease . |
| PubMedID- 23091810 | We investigated whether apoe genotype determines the disease outcome in hepatitis b virus (hbv)-infected individuals, and verified the association between apoe genotype and the occurrence of hepatocellular carcinoma (hcc) in patients with chronic liver diseases of various etiologies. |
| PubMedID- 22175908 | Aim: malignancies that include hepatocellular carcinoma often occurred in patients with chronic liver disease. |
| PubMedID- 23633285 | Purpose: to determine whether the presence of a hypovascular nodule in the liver showing hypointensity on hepatocyte-phase of gadoxetic acid-enhanced magnetic resonance imaging (eob-mri) is a risk factor for hypervascular hepatocellular carcinoma (hcc) in patients with chronic liver disease. |
| PubMedID- 20619382 | Background: hepatitis c virus (hcv) causes chronic liver disease that often leads to cirrhosis and hepatocellular carcinoma. |
| PubMedID- 21656309 | Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. |
| PubMedID- 21920517 | hepatocellular carcinoma in patients with chronic liver disease: a comparison of gadoxetic acid-enhanced mri and multiphasic mdct. |
| PubMedID- 24112253 | Objective: to determine the frequency of development of hepatocellular carcinoma in patients with chronic liver disease secondary to hepatitis c who had achieved sustained virological response with interferon and ribavirin therapy. |
| PubMedID- 21139506 | Conclusions: administration of double dose of gd-eob-dtpa provided better arterial enhancement of hepatocellular carcinomas in patients with chronic liver disease, and also improved the lesion-liver contrast in hepatocyte-phase images in patients with child-pugh class b disease. |
| PubMedID- 22258434 | Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study. |
| PubMedID- 26327775 | Here we report the case of a patient with a large hepatocellular carcinoma arising from chronic liver disease. |
| PubMedID- 21569410 | hepatocellular carcinoma (hcc) results from chronic liver disease and is the most common malignancy of the liver 1. |
| PubMedID- 22956868 | hepatocellular carcinoma usually occurs in patients with chronic parenchymal liver disease, especially chronic infection with hepatitis b or c virus or cirrhosis.1 the results of treatment are unsatisfactory because hepatocellular carcinoma cannot be diagnosed in its early stages, and symptoms only appear when the disease is advanced. |
| PubMedID- 24073300 | Pure laparoscopic hepatectomy for hepatocellular carcinoma with chronic liver disease. |
| PubMedID- 26386160 | As this cohort ages, progressive hcv-related liver disease leading to cirrhosis and hepatocellular carcinoma (hcc) will place a significant burden on the healthcare system. |
| PubMedID- 22707881 | Status quo of chronic liver diseases, including hepatocellular carcinoma, in mongolia. |
| PubMedID- 26182318 | Development of hepatocellular carcinoma (hcc) in patients with autoimmune liver disease is less common than in those with other types of chronic liver disease. |
| PubMedID- 22116467 | Loss of retinoid-containing lipid droplets upon hepatic stellate cell (hsc) activation is one of the first events in the development of liver disease leading to hepatocellular carcinoma. |
| PubMedID- 22675639 | Serum afp is a debated but routinely used marker for hepatocellular carcinoma (hcc) in patients with chronic liver disease 5. |
Page: 1 2